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The atypical two-component system (TCS) AbrC1/C2/C3 (encoded by SCO4598, SCO4597, and SCO4596), comprising two histi-
dine kinases (HKs) and a response regulator (RR), is crucial for antibiotic production in Streptomyces coelicolor and for mor-
phological differentiation under certain nutritional conditions. In this study, we demonstrate that deletion of the RR-encoding
gene, abrC3 (SCO4596), results in a dramatic decrease in actinorhodin (ACT) and undecylprodiginine (RED) production and
delays morphological development. In contrast, the overexpression of abrC3 in the parent strain leads to a 33% increase in ACT
production in liquid medium. Transcriptomic analysis and chromatin immunoprecipitation with microarray technology (ChIP-
chip) analysis of theabrC3mutant and the parent strain revealed that AbrC3 directly controls ACT production by binding to
the actII-ORF4 promoter region; this was independently verified by in vitroDNA-binding assays. This binding is dependent
on the sequence 5=-GAASGSGRMS-3=. In contrast, the regulation of RED production is not due to direct binding of AbrC3 to
either the redZ or redD promoter region. This study also revealed other members of the AbrC3 regulon: AbrC3 is a positive auto-
regulator which also binds to the promoter regions of SCO0736, bdtA (SCO3328), absR1 (SCO6992), and SCO6809. The direct
targets share the 10-base consensus binding sequence andmay be responsible for some of the phenotypes of theabrC3mutant.
The identification of the AbrC3 regulon as part of the complex regulatory network governing antibiotic production widens our
knowledge regarding TCS involvement in control of antibiotic synthesis andmay contribute to the rational design of new hyper-
producer host strains through genetic manipulation of such systems.
Antibiotic production in Streptomyces species is a complex pro-cess controlled by multiple factors through intricate genetic
networks (1–4). These organisms inhabit the soil, where the envi-
ronmental conditions are extremely variable, and must therefore
compete with other organisms for scarce nutrients. Secretion of
antibiotics provides a selective advantage to survive in this adverse
environment (5), where it is important to respond quickly to dif-
ferent stimuli. Two-component systems (TCSs) are perhaps the
most important signal transduction mechanism in bacteria (6, 7;
http://mistdb.com/; http://www.p2cs.org/index.php?PHPSESSI
D4c2f13770410fa0fab046d10e6cf90d1). Their relative abun-
dance in a genome reflects an organism’s ability to adapt to differ-
ent conditions, with less abundance, for example, in pathogens
such as Chlamydia and Rickettsia than in free-living organisms,
such as Streptomyces or Myxococcus, where more than 60 TCSs are
present in their respective genomes (8–10). The only bacterial
species lacking TCSs are intracellular pathogens (e.g.,Mycoplasma
species) and endosymbionts (e.g., Amoebophilus species) with se-
verely reduced genomes (11).
The Streptomyces AbrC1/C2/C3 gene cluster (SCO4598,
SCO4597, and SCO4596) constitutes an atypical TCS in that it
encodes two histidine kinases (HKs) (AbrC1 and AbrC2) of group
II and one response regulator (RR) (AbrC3) belonging to the NarL
group of the helix-turn-helix (HTH) LuxR family regulators (12).
It is conserved across all Streptomyces species sequenced to date
and has been found to be critical for antibiotic production and
morphological differentiation in Streptomyces coelicolor under
certain culture conditions (13). Both kinases of the system (AbrC1
and AbrC2) share high similarity in their kinase domains (85%),
although AbrC1 lacks an internal domain of 50 amino acid resi-
dues of AbrC2. Independent promoters control the three genes,
even though the genes for HKs and cognate RRs of TCSs are usu-
ally arranged in operons (14); these features are conserved in all
sequenced Streptomyces species, suggesting the importance of reg-
ulation of these genes. The RR, AbrC3, has orthologues in more
than 20 Streptomyces species sequenced, sharing more than 90%
amino acid identity among them. The deletion of these three genes
correlates with delayed morphological differentiation and a
marked reduction in the production of the following antibiotics in
S. coelicolor M145: actinorhodin (ACT), undecylprodiginine
(RED), and the calcium-dependent antibiotic (CDA) (13).
In this work, we present a detailed genetic, physiological, and
biochemical characterization of this important regulatory system.
We show that deletion of abrC3 alone leads to a dramatic reduc-
tion in ACT and RED production and in morphological develop-
ment in S. coelicolor. Moreover, overexpression of the AbrC3 reg-
ulator yields high ACT production in both S. coelicolor and S.
lividans. To better characterize the pleiotropic effects exhibited by
theabrC3 mutant, we conducted a global transcriptome analysis
comparing the abrC3 mutant and the parental strain and
showed that the low-level production of ACT observed in the
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abrC3 mutant was due to a general downregulation of transcrip-
tion of the act gene cluster. Other regulatory genes previously
associated with antibiotic production, such as the sIHF gene
(SCO1480) (15, 16), afsS (SCO4425) (17, 18), and absR1 (SCO6992)
(19), and with morphological development, for example, wblE
(SCO5240) (20, 21) and bdtA (SCO3328) (22, 23), were also down-
regulated in this mutant. Furthermore, through chromatin immuno-
precipitation with microarray technology (ChIP-chip) analyses, we
demonstrated a direct regulation of act gene expression through
AbrC3, and we provided independent verification with in vitroDNA-
binding studies. This genomewide study also revealed additional di-
rect DNA targets of AbrC3. All of these targets share a 10-bp sequence
(5=-GAASGSGRMS-3=; SG or C, R A or G, and M A or C),
and we have shown, by mutagenesis, that it is indispensable for the
binding of AbrC3 to the actII-ORF4promoter region. Therefore, this
sequence defines the putative consensus AbrC3 binding site.
MATERIALS AND METHODS
Strains, media, and culture conditions. Escherichia coli strain BW25113
(pIJ790) (containing the Red system) is an E. coli K-12 (araBAD
rhaBAD) derivative (24), and nonmethylating ET12567(pUZ8002) is a
damdcmhsdS cat tet strain harboring the tra genes in the nontransmissible
RP4-derivative plasmid pUZ8002 (25). Both strains were grown in Luria-
Bertani (LB) liquid broth or on LB agar (26). For CDA bioassays, a parent
strain of Bacillus subtilis (CECT 4522) was grown as an overlay on NA
medium (27). S. lividans 66, S. coelicolor M145 (prototroph; SCP1
SCP2), and mutant strains were grown on R2YE and MS solid media for
transformation and sporulation, respectively (28). The liquid cultures
used for transcriptional profiling and ChIP-chip analyses were grown in
nutrient broth (NB) at 30°C in 500-ml baffled flasks containing 160 ml of
medium (each) in a shaking orbital incubator (250 rpm). Where neces-
sary, the medium was supplemented with antibiotics (for E. coli media,
100 g ml1 for ampicillin, 50 g ml1 for apramycin, 50 g ml1 for
kanamycin, 34 g ml1 for chloramphenicol, and 25 g ml1 for nali-
dixic acid; and for S. coelicolor media, 20 g ml1 for neomycin, 50 g
ml1 for apramycin, and 20 g ml1 for hygromycin).
Nucleic acid manipulations. Plasmid isolation, restriction enzyme
digestion, ligation, and transformation of E. coli and S. coelicolor were
carried out as described by Sambrook et al. (26) and Kieser et al. (28),
respectively. The plasmids and cosmids used are listed in Table S1 in the
supplemental material. Total genomic DNA (gDNA) from S. coelicolor
was isolated from 24- to 36-h cultures in Trypticase soy broth (TSB),
following the procedure described by Hopwood et al. (27), but scaled to 1
to 2 g of mycelium.
Where needed, the DNA was sequenced on both strands by using a
PerkinElmer ABI Prism 377 DNA sequencer. In silico plasmid designs
were obtained with Gene Construction kit software (GCK; Texco).
Plasmid construction. The integrative plasmid pSETabrC3 was con-
structed by cloning the abrC3 gene under the regulation of its own pro-
moter into the Streptomyces integrative shuttle plasmid pSET152t, using
NdeI and BamHI restriction sites. This plasmid was used for complemen-
tation of the abrC3 mutant strain (see Table S1 in the supplemental
material).
The low-copy-number pHJLAbrC3 plasmid, derived from pHJL401
(29), was obtained by cloning the abrC3 gene with its own promoter into
pHJL401, using BamHI and EcoRI sites.
The new plasmids were introduced into the corresponding Streptomy-
ces strains by protoplast transformation as previously described (28).
The E. coli expression vector pETabrC3 was a derivative of the
pET22(b) plasmid obtained by cloning the coding sequence for AbrC3,
previously amplified by PCR with the corresponding oligonucleotides
SRG-001 and SRG-002 (see Table S2 in the supplemental material), into
the NdeI and XhoI sites of the polylinker.
AbrC3 overexpression in E. coli. Cultures of E. coli BL21(DE3) trans-
formed with pETabrC3 were induced with 1 mM IPTG (isopropyl--D-
thiogalactopyranoside) to overproduce AbrC3-6His, subsequently puri-
fied with Ni-nitrilotriacetic acid (Ni-NTA) (Qiagen) as described before
(30), and used to immunize two rabbits in order to obtain anti-AbrC3
antibodies.
Mutant construction (abrC3 knockout). The PCR-targeted system
established by Gust et al. (31) was used to replace the complete coding
sequence of abrC3 (SCO4596) in cosmid SCD20 (http://streptomyces.org
.uk/) with the apramycin resistance gene aac(3)IV. The primers used to
amplify the mutagenesis cassette, with pIJ773 as the template, are listed in
Table S2 in the supplemental material. The mutated cosmid SCD20
abrC3::acc(3)IV, obtained in E. coli BW25113(pIJ790), was demethy-
lated in E. coli ET12567(pUZ8002) and transferred by conjugation to S.
coelicolor M145. The desired double recombinants, carrying apramycin
resistance while being sensitive to kanamycin (the selection marker for the
vector sequences), were selected. Southern blotting and PCR assays con-
firmed the deletion of the abrC3 gene in S. coelicolor M145.
RNA isolation and DNA microarray analysis. For RNA extraction
from the S. coelicolor parent strain and abrC3 mutant strains, 160 ml of
NB medium was inoculated into 500-ml baffled flasks with 4  106
spores/ml and incubated at 30°C for 36, 48, and 60 h. Two biological
replicates and three technical replicates were used for each time point.
Prior to RNA isolation using a modified version of the mirVana miRNA
isolation kit protocol (Life Technologies), cells from 20 ml of culture were
harvested and suspended in RNA-protect bacterial reagent (Qiagen). Fol-
lowing mycelial lysis with lysozyme (15 mg/ml in Tris-EDTA [TE] at
room temperature), 3 volumes of RLT buffer from an RNeasy Plus mini-
kit (Qiagen) was added, and mycelia were disrupted using a TissueLyser
(Qiagen) for 4 min. The lysate was clarified by centrifugation, extracted
twice with phenol-chloroform and once with chloroform, and applied to
a gDNA eliminator filter (RNeasy Plus minikit; Qiagen) to remove any
contaminating DNA. After this step, 1.25 volumes of 100% ethanol was
added, and the total RNAs (including small RNAs) were purified through
mirVana columns following the manufacturer’s recommendations. The
quality and concentration of RNA were assayed using a Bioanalyzer 2100
system (Agilent) and spectrophotometric assays (model ND1000 Nano-
drop instrument).
The S. coelicolor IJISS 105K microarrays used for ChIP-chip and high-
resolution transcriptome analysis were designed by the Functional
Genomics Laboratory of Surrey University (United Kingdom) in collab-
oration with Oxford Gene Technology (United Kingdom), and they were
manufactured by Agilent. Each microarray comprised almost 105,000
unique 60-mers, with an average genome spacing of 35 nucleotides. The
105K probes were designed to cover the coding strands of all known pro-
tein coding genes and both strands of all intergenic regions. A cDNA
versus reference gDNA microarray two-color experimental design was
utilized for the transcriptomic comparison of S. coelicolor M145 and the
abrC3 mutant. All Cy3-cDNA and Cy5-gDNA labeling reactions and
hybridization assays were performed according to the recommendations
described at http://www.surrey.ac.uk/fhms/microarrays/Downloads/Pro
tocols/index.htm.
All hybridized arrays (expression and ChIP-chip arrays) were scanned
using an Agilent Technologies microarray scanner, and resultant images
were analyzed using Agilent Technologies Feature Extraction software
(version 9.1.3.1.), with local background correction.
Raw gene expression data were normalized within the statistical com-
puting environment R by using the LIMMA package (32–34) global me-
dian within-array normalization, followed by “scale” across-array nor-
malization. Probes that were flagged as poor quality by Agilent Feature
Extraction were removed from the analysis. A gene’s expression was cal-
culated by averaging across all remaining good-quality probes that tar-
geted the annotated coding sequence. Expression data sets were analyzed
using rank product analysis via RankProdIt (http://strep-microarray.sbs
.surrey.ac.uk/RankProducts), a Web-based interactive analysis tool (35).
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Differentially expressed genes were identified as having a PFP (probability
of false prediction) value of 0.15, equal to a false discovery rate of ap-
proximately 15% and at a level that has been validated experimentally in
this study and others (e.g., see reference 36). A BED-formatted track with
the average log2 expression data to be visualized across the chromosome,
using the UCSC microbial gene browser (http://microbes.ucsc.edu/), was
generated using in-house Perl scripts.
qRT-PCR. Real-time quantitative reverse transcription-PCR (qRT-
PCR) was used to validate the microarray data. Specific primers and
probes for the tested genes were designed using the Primer3 Web-based
tool (see Table S2 in the supplemental material). Five-microgram RNA
samples were treated with RNase-free DNase I (Promega) according to
the manufacturer’s instructions. One microgram of the resulting RNA
was used as the template for cDNA synthesis using iScript reverse tran-
scription supermix for RT-qPCR (Bio-Rad) in 20-l reaction volumes.
The samples were diluted 1:1 with distilled water, and 5l was used in the
quantitative PCR, with 10 pmol (each) of forward and reverse primers, 2.5
pmol of 6-carboxyfluorescein (FAM)- and 6-carboxytetramethylrhod-
amine (TAMRA)-dual-labeled specific probe, and 12.5 l SsoFast Probes
supermix with ROX master mix (Bio-Rad) in a final volume of 25l. Each
assay was performed in duplicate, using a CFX96 Touch real-time PCR
detection system (Bio-Rad). Control PCRs were included to verify that
there was no DNA contamination (mixtures without reverse transcriptase
as an enzyme negative control). Relative quantification of gene expression
was performed by the CT method, a comparative qPCR data analysis
(37) in which the threshold cycle (CT) values of the genes of interest
obtained from two different experimental RNA samples (parent strain
and mutant) are directly normalized to the CT values of a housekeeping
gene (gene control) in the same samples. First, the difference between the
CT values of the gene of interest between parent and mutant strains
(CT
1) and the difference between theCT values of the housekeeping gene
between both strains (CT
2) are calculated for each experimental sample.
Next, the difference in theCT values between the gene of interest and the
control gene (CT  CT
1  CT
2) is calculated. The fold change in
expression of the gene of interest between the two experimental samples
(parent strain and mutant) is then equal to 2CT. The hrdB (SCO5820)
gene was the internal control used to quantify the relative expression of
the target genes, since its expression level remained constant under all the
conditions analyzed by the microarray. The expression ratios measured by
microarrays and by qRT-PCR assays were plotted, and the linear correla-
tion coefficient was calculated (y 1.60x 0.09; R2 0.93) (see Table 3).
ChIP-chip analysis. For ChIP, three 20-ml aliquots from the same
cultures used in the microarray gene expression analysis were taken (S.
coelicolor M145 and abrC3 mutant strains, incubated at 30°C for 36, 48,
and 60 h). These samples were treated with formaldehyde (Sigma) at a
final concentration of 1%. Cross-linking was allowed to proceed for 30
min at 30°C. Glycine, at a final concentration of 0.5 M, was added to stop
the cross-linking for a further 5 min at 30°C. Mycelium was harvested by
centrifugation and frozen at 20°C. Chromatins with an average size
range of 300 to 600 bp was obtained as described by Bucca et al. (38). ChIP
was carried out as described before (38), using purified rabbit polyclonal
antibodies against AbrC3 obtained in our laboratory. The IgG fraction
containing anti-AbrC3 polyclonal antibodies and the fraction from pre-
immune serum from the same rabbit used for immunization were puri-
fied by affinity chromatography using CNBr-activated Sepharose 4B
(Sigma). The chromatins purified from S. coelicolor M145 and theabrC3
mutant strain were sonicated to obtain an average size range of 300 to 600
bp. DNA samples were immunoprecipitated with either AbrC3 antibody
(AbIP) or a mock control (NoIP), purified, labeled with Cy3- or Cy5-
dCTP, respectively, and hybridized to 105K arrays as described above.
Two biological replicates were hybridized such that the AbIP/NoIP sam-
ples from each of the two replicates were labeled in opposite dye orienta-
tions to control for dye bias. Arrays were scanned and processed as de-
scribed above.
The raw data were normalized within R (as described above), using the
across-array scale function of the LIMMA package only. Again, poor-
quality probes were filtered out from downstream analysis. The data anal-
ysis was carried out essentially as described by Allenby et al. (39). Values
for significant probes (P	 0.05), defined on the basis of a nonparametric
t test run with multtest and pnorm (within R), were plotted as ratios
[(parent strain AbIP value/parent strain NoIP value)/(abrC3 AbIP val-
ue/abrC3 NoIP value)]. The probes most differentially enriched for
AbrC3 binding between the parent strain and the mutant were selected
from the right tail of the distribution. Probes within 3 kb (based on their
annotated genomic locations) of each other were grouped, and genomic
regions of interest were those in which at least two enriched probes were
found. Finally, tracks (BED files) to visualize the data across the chromo-
some, using the UCSC microbial genome browser (http://microbes.ucsc
.edu/), were generated using in-house Perl scripts.
Western blot assays. Total protein extracts were obtained from 5-ml
samples (in triplicate) of the cultures used for the global analysis described
above. The proteins were resolved by SDS-PAGE (15% polyacrylamide in
a MiniProtean II system; Bio-Rad). After transfer to Immobilon-P mem-
branes (Millipore), the proteins were incubated with prepurified poly-
clonal anti-AbrC3 at a 1:100,000 dilution. AbrC3 was detected by chemi-
luminescence with ECL Western blotting detection reagents following the
manufacturer’s instructions (GE Healthcare), using horseradish peroxi-
dase-coupled anti-rabbit secondary antibody.
In vitro DNA-binding assays. Gel shift assays were conducted using
DNA fragments containing the intergenic region (up to400 bp from the
translational start point) plus another 100 bp (
100 bp) inside the open
reading frame (ORF), amplified using the corresponding primers in a
PCR (see Table S2 in the supplemental material). These fragments were 5=
radiolabeled with T4 polynucleotide kinase in the presence of [-
32P]dATP, and the unreacted [-32P]dATP was removed using Illustra
ProbeQuant G-50 microcolumns (GE Healthcare). The purified proteins
were incubated in 50 mM Tris-HCl, pH 7, 25 mM MgCl2, 0.1 M NaCl at
30°C for 30 min prior to binding. Different concentrations of the proteins
were then incubated with the labeled DNA probes (10 fmol) in binding
buffer (10 mM Tris-HCl, pH 7.8, 2 mM dithiothreitol [DTT], 150 mM
NaCl, 10% glycerol, and 45 ng of sheared salmon sperm DNA) for 30 min
at 30°C. Protein-bound DNA and free DNA were resolved in a 5% acryl-
amide gel in 0.5 TBE buffer (44.5 mM Tris, 44.5 mM boric acid, 1 mM
EDTA, pH 8) at 4°C. The gel was exposed overnight and bands revealed by
autoradiography. As a control, an unlabeled specific probe (S) (100-fold
molar excess) or nonspecific competitor DNA (N) (100-fold molar excess
of sheared salmon sperm DNA) was added to the reaction mixture. Also,
a bovine serum albumin (BSA) (4 M) protein-binding reaction was
conducted as a control to demonstrate the specificity of the electropho-
retic mobility shift assays (EMSAs).
Identification of the putative AbrC3 binding site. The Regulatory
Sequence Analysis Tools (RSAT) “consensus” alignment (http://rsat.ulb
.ac.be/) was used to identify putative conserved DNA sequences in the
upstream regions (with respect to the annotated translational start codon)
of the AbrC3 target genes (including 100 bp into the respective ORF)
identified from the ChIP-chip experiment. The functionality of the con-
served 10-base sequence identified with RSAT consensus alignment was
demonstrated by eliminating it from actII-ORF4p. The elimination of this
sequence was achieved using overlap PCR. As the first step, PCR ampli-
cons were made using primers SRG95-SRG97 and SRG96-SRG90 (see
Table S2 in the supplemental material). Using both resulting fragments as
templates, a second PCR was conducted using oligonucleotides SRG95
and SRG90. The final fragment, with EcoRI and PstI sites in the ends, was
cloned into the pGEM-T Easy plasmid. The elimination of the consensus
binding sequence from absR1p was performed by PCR amplification of
the region with the oligonucleotides SRG-116 and SRG073 (see Table S2).
Antibiotic production measurements. Production of ACT in liquid
cultures was determined by measuring the A640 (ε640  25,320) in the
supernatants of samples treated with 1 N KOH overnight at 4°C and then
centrifuged (15,000 g, 10 min). The experiments were all performed in
AbrC3 Regulon of Streptomyces coelicolor
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triplicate, and the dry weights of samples at different times were measured
to monitor culture growth.
Chromatographic analysis. Liquid cultures were centrifuged, and su-
pernatants and cell pellets were extracted separately. The supernatants
were extracted twice with an equal volume of ethyl acetate containing 1%
formic acid. The cell pellets were extracted with acetonitrile. In each case,
the solvent was evaporated and the residue redissolved in a small volume
of a mixture of dimethyl sulfoxide and methanol (50:50). These samples
were chromatographed as previously described (40).
Microarray data accession numbers.All microarray data are MIAME
compliant, and the raw and normalized data have been deposited in
ArrayExpress under accession number E-MTAB-1453. The raw and nor-
malized ChIP-chip data have been deposited in ArrayExpress under ac-
cession number E-MTAB-1451.
RESULTS
Influence of the AbrC3 RR in antibiotic production in Strepto-
myces.The S. coelicolorabrC3 mutant strain was generated using
a PCR-targeting approach described by Gust et al. (31), which
replaced the entire coding region of the gene with an apramycin
resistance cassette (see Materials and Methods). Phenotypic anal-
ysis of growth and antibiotic production of the parent strain
(strain M145), the abrC3 mutant, and the abrC1C2C3 triple
mutant, which was described previously (13), revealed significant
differences among the three strains (Fig. 1A). ACT and RED pro-
duction was highly diminished in both the triple and single mu-
tants compared to the parent strain on nutrient agar medium. In
contrast, CDA production in the mutant lacking only the response
regulator (abrC3 mutant) was unaffected, while it was clearly
diminished in the triple mutant. A delay in morphological differ-
entiation on solid medium was also observed in both mutants.
When the strains were grown in liquid NB, the abrC3 mutant
produced almost no ACT. Complementation of the abrC3 mu-
tant with the integrative plasmid pSET152-abrC3 restored ACT
production to almost the parent strain levels (Fig. 1B). Both mu-
tants and the parent strain produced similar growth curves (e.g.,
see Fig. S1A in the supplemental material), indicating that growth
per se was not compromised in the mutant strains.
Complementation with pSET152-abrC3 was also tested on
solid medium (NA). ACT production and morphological differ-
entiation were complemented, and there was a partial comple-
mentation of RED production (Fig. 1B). It was noted that ACT
production on solid medium was found to be higher in the com-
plemented strain than in the parent strain harboring the empty
plasmid; pSET152 derivatives tend to exist as tandem duplications
in the genome (C. P. Smith, unpublished data), and it is therefore
conceivable that an enhanced level of AbrC3 was responsible for
the elevated ACT production.
It is noteworthy that quantification of ACT production from
M145 cells transformed with abrC3 moderately overexpressed
from the low-copy-number plasmid pHJLabrC3 showed 33%
more ACT production at 5 days than that of the plasmid control,
pHJL401 (Fig. 2). This result was consistent with AbrC3 acting as
a positive regulator of the ACT gene cluster and offers the possi-
bility of using this low-copy-number plasmid to enhance antibi-
otic production. Indeed, when pHJLabrC3 was introduced into
the S. lividans 66 strain, the normally silent ACT pathway was
induced to even higher levels than those in S. coelicolor (Fig. 2).
Effects of abrC3 deletion on the S. coelicolor transcriptome.
Comparison of genomewide mRNA abundances between the S.
coelicolor M145 parent strain and its congenicabrC3 mutant was
performed. Samples were taken after 36, 48, and 60 h of growth
(see Fig. S1A in the supplemental material), and antibiotic pro-
duction at these time points was assessed by high-pressure liquid
chromatography (HPLC). As shown in Fig. S1B, at 60 h of growth
there was an ACT production peak in the parent strain but not the
mutant strain, in both the supernatant and cell extract fractions.
Likewise, RED production was observed only in parent strain cell
extracts. In addition, the level of AbrC3 protein in the parent
strain and its absence in the abrC3 mutant strain at the three
FIG 1 Phenotypic study of the mutants and complementation. (A) Production of the antibiotics ACT (72 h), CDA (bioassay against B. subtilis at 48 h), and RED
(48 h) by the parent strain (M145) and the abrC1C2C3 and abrC3 mutants, as well as their morphological differentiation (MD) on NA medium. (B)
Complementation of ACT production by integration of plasmid pSETabrC3 in the abrC3 mutant strain in liquid NB medium (ACT liquid), ACT (72 h) and
RED (48 h) production, and their morphological differentiation (MD) on solid NA medium.
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sampling points used in this study were confirmed by Western
blotting using anti-AbrC3 antibodies (see Fig. S1C).
Total RNA samples from the abrC3 mutant and the parent
strain, cultivated in NB medium for 36, 48, and 60 h, were labeled
and hybridized to 60-mer, high-density, whole-genome S. coeli-
color IJSS 105K DNA microarrays as described by Lewis et al. (41)
(see Materials and Methods). Analysis of the DNA microarray
data from two independent experiments revealed that only 32
genes were downregulated and 8 genes were upregulated at statis-
tically significant levels (Benjamini and Hochberg-corrected P
values of	0.005 and PFP values of	0.15) (Tables 1 and 2). Of the
32 genes that showed significantly reduced expression in the mu-
tant strain, 16 corresponded to the entire act cluster, including
actII-ORF4 (SCO5085), which encodes the SARP pathway-spe-
cific regulator of the act cluster (Table 1). Three other significantly
downregulated genes, i.e., the sIHF gene (SCO1480) (15, 16), afsS
(SCO4425) (17, 18), and absR1 (SCO6992) (19), encode regula-
tory proteins and were previously related to antibiotic regulation.
An additional gene, SCO1839, encoding a putative transcriptional
regulator with a helix-turn-helix motif, and two genes involved in
morphological development, i.e., wblE (SCO5240; encodes an ex-
tracytoplasmic function [ECF] sigma factor [20, 21]) and bdtA
(SCO3328; encodes a putative transcription factor regulated by
BldD and forms an operon with SCO3327 [22, 23]), were also
significantly downregulated. The acdH gene (SCO2779), encoding
an acyl-coenzyme A (acyl-CoA) dehydrogenase involved in
branched-amino-acid catabolism in S. coelicolor and S. avermitilis
(42), and SCO3218, a gene of unknown function located in the cda
gene cluster, were also significantly downregulated in the mutant
(Table 1). Among the eight significantly upregulated genes were
FIG 2 Overexpression of AbrC3 in S. coelicolor and S. lividans. ACT production
is shown for S. coelicolorM145 (left) and S. lividans 66 (right) transformed with
the low-copy-number plasmid pHJL401 (control) and its derivative,
pHJLabrC3, in NB medium at 5 days. Error bars correspond to three indepen-
dent experiments. The bottom panels show photographs of the corresponding
supernatants.
TABLE 1 Selected genes significantly downregulated in the abrC3 mutant relative to the parent strain M145 (P	 0.005 and/or PFP	 0.15)
Gene Function P value PFP Fold change Time (h)
SCO5071 Hydroxylacyl-CoA dehydrogenase 0 0.002 1.77 48
SCO5072 Hydroxylacyl-CoA dehydrogenase 0 0 2.13 48
SCO5073 Putative oxidoreductase 0 0 2.09 48
SCO5074 Putative dehydratase 0 0 3.25 48
SCO5075/ORF4 Putative oxidoreductase 0 0 2.23 48
SCO5077/actVA2 Hypothetical protein 0 0.001 1.99 48
SCO5078/actVA3 Hypothetical protein 0 0 2.28 48
SCO5079/actVA4 Conserved hypothetical protein 0 0 2.28 48
SCO5080/actVA5 Putative hydrolase 0 0 2.25 48
SCO5081/actVA6 Hypothetical protein 0 0 2.59 48
SCO5085/actII-ORF4 Actinorhodin cluster activator protein 0 0 2.85 48
SCO5086/actIII Ketoacyl reductase 0 0 2.80 48
SCO5087/actI-ORF1 Actinorhodin polyketide beta-ketoacyl synthase alpha subunit 0 0.008 1.83 48
SCO5088/actI-ORF2 Actinorhodin polyketide beta-ketoacyl synthase beta subunit 0 0.003 1.92 48
SCO5089/actI-ORF3 Actinorhodin polyketide synthase acyl carrier protein 0 0 3.11 48
SCO5090/actVII Actinorhodin polyketide synthase bifunctional cyclase/dehydratase 0.0002 0.060 1.63 48
SCO0045 Hypothetical protein 0.0005 0.127 1.23 48
SCO0682 Hypothetical protein SCF15.03c 0.0001 0.053 1.25 48
SCO0736 Putative secreted protein 0 0.019 1.45 60
SCO1480/sIHF gene Streptomyces integration host factor 0.0003 0.090 1.28 48
SCO1550 Putative small membrane protein 0.0002 0.070 1.35 36
SCO1839 Putative transcriptional regulator 0.0005 0.120 1.40 36
SCO2113/bfr Putative bacterioferritin 0.0001 0.050 1.24 48
SCO2779/acdH Acyl-CoA dehydrogenase 0.0006 0.145 1.27 36
SCO3218 Putative small conserved hypothetical protein 0 0.018 1.39 36
SCO3327 Hypothetical protein 0.0002 0.051 1.41 60
SCO3328/bdtA Hypothetical protein 0.0002 0.055 1.47 60
SCO4425/afsS Sigma-like protein 0 0.001 1.83 48
SCO5240/wblE Hypothetical protein 0.0007 0.158 1.36 48
SCO5915 Fatty acid desaturase 0.0003 0.081 1.39 36
SCO6205 Putative threonine dehydrogenase 0.0007 0.158 1.43 48
SCO6992/absR1 Regulatory protein 0.0001 0.056 1.57 60
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the ribosomal protein gene rplP (SCO4709) and the chpE gene
(SCO1800) (43) (Table 2).
Several of the differentially expressed genes were selected for
independent validation by qRT-PCR (Table 3). These included
the downregulated genes acdH (SCO2779), encoding acyl-CoA
dehydrogenase; absR1 (SCO6992), encoding an activator of sec-
ondary metabolism; afsS (SCO4425), a sigma-like protein gene;
and the specific regulator of the ACT cluster, actII-ORF4
(SCO5085). We also analyzed the expression levels of one of the
genes that was differentially upregulated in the mutant and en-
codes the 50S ribosomal protein L16 (rplP; SCO4709). Moreover,
we included both histidine kinase genes of the TCS, abrC1 and
abrC2 (SCO4598 and SCO4597), in order to confirm their non-
differential expression levels. A good correlation of transcript
measurements from the microarray data and the qRT-PCR data
(yielding a correlation regression coefficient of 0.93) was obtained
(Table 3). Note that the validation of differential expression for
SCO4709 confirms the use of 0.15 as a suitable PFP threshold for
determining significance, similar to that found in other expres-
sion-based studies (e.g., see reference 36).
In vivo identification of AbrC3 targets on the S. coelicolor
genome. The genes exhibiting marked AbrC3-dependent changes
in expression could be regulated directly by AbrC3 or could be
regulated by transcription factors downstream of AbrC3, in a pos-
sible regulatory cascade. Hence, to identify genes directly regu-
lated by AbrC3, by interaction with their respective promoter re-
gions, a genomewide ChIP-chip approach was undertaken.
Samples from the same cultures and time points used for the tran-
scriptomic analysis (described above) were treated with formalde-
hyde to cross-link proteins to DNA and then were subjected to
chromatin immunoprecipitation with either purified anti-AbrC3
antibodies or mock controls (see Materials and Methods). The
immunoprecipitated DNA from each strain was labeled with Cy3
or Cy5 in a dye-balanced direct comparison experimental design
and hybridized to the above-mentioned 105K S. coelicolor mi-
croarrays (see Materials and Methods). Two biological replicate
experiments were conducted, and significantly enriched genomic
binding regions in the parent strain relative to theabrC3 mutant
were identified. We identified 617, 520, and 458 AbrC-enriched
(AbrC3 DNA targets bound at significantly higher levels in the
parent strain than in the mutant) regions from chromatins iso-
lated at 36 h, 48 h, and 60 h of growth, respectively. The genes with
high enrichment ratios are summarized in Table 4, and the over-
lapping targets in ChIP-chip and transcriptomic analyses are
shown in Table 5.
This analysis demonstrated that the AbrC3 protein was able
to bind in vivo, with high efficiency, to the promoter of the path-
way-specific regulator gene of the ACT cluster, actII-ORF4p
(SCO5085) (Tables 4 and 5), at 36 h. No binding was detectable at
48 h or 60 h. This result suggests that the downregulation of the act
gene cluster (Table 1) was due to a direct regulation of actII-ORF4
exerted by AbrC3 at around 36 h of culture.
Efficient binding of AbrC3 to its own promoter, abrC3p
(SCO4596), was also observed at 60 h (Table 5), indicating that
AbrC3 is an autoregulator. No binding to the promoters of the
histidine kinase-encoding genes of the AbrC system (abrC1 and
abrC2) or differential expression of these two genes under the
experimental conditions used was observed (Table 3).
In vivo binding of AbrC3 to several of the promoters of the
genes previously identified as downregulated was observed, and
therefore their expression is very likely directly controlled by
AbrC3 (Table 5). Weaker AbrC3 enrichment was observed up-
stream of SCO1480 (sIHF gene), SCO1550, the regulator gene
SCO1839, the acyl-CoA dehydrogenase AcdH gene (SCO2779),
and the transcription factor WblE gene (SCO5240), and no bind-
ing at all was observed for three of the differentially expressed
genes identified in our transcriptome analysis: SCO0682,
SCO3218, and afsS (SCO4425) (data not shown). We hypothesize
that these genes could be regulated by factors downstream of
AbrC3, in a possible regulatory cascade, or that additional tran-
scription factors/cofactors bound to the promoter regions
blocked access of the anti-AbrC3 antibody, yielding false-negative
results (for example, see reference 39).
Among the significantly upregulated genes, we detected
binding of AbrC3 only to the putative promoters of the rplP
(SCO4709) and SCO6809 genes (Table 5), suggesting that the
other six upregulated genes may be regulated by downstream fac-
tors.
EMSAs were conducted to test the in vitro binding capacity of
the protein for the DNA sequences upstream of the corresponding
genes that showed AbrC3 binding in vivo. DNA fragments com-
prising the intergenic region (up to 400 bp from the transla-
TABLE 3 qRT-PCR validation of five differentially expressed genes
identified from microarray dataa
Gene Function
Expression ratio (fold
change)b
Microarray qRT-PCR
SCO2779/acdH Acyl-CoA dehydrogenase 1.27 2.13
SCO4425/afsS Sigma-like protein 1.83 3.06
SCO4597/abrC2 Sensor kinase 1.085 1.12
SCO4598/abrC1 Sensor kinase 1.04 1.08
SCO5085/actII-ORF4 ACT cluster activation
protein
2.85 3.90
SCO6992/absR1 Regulatory protein 1.57 3.65
SCO4709/rplP 50S ribosomal protein L16 1.16 2.11
a Linear regression fit analysis was applied, and a correlation coefficient was used to
validate the data (y 1.60x 0.09; R2  0.93).
b Parent strain M145 versus abrC3 mutant.
TABLE 2 Selected genes upregulated in the abrC3 mutant relative to
the parent strain M145 (P	 0.005 and/or PFP	 0.15)
Gene Function P value PFP
Fold
change
Time
(h)
SCO1800/chpE Putative small secreted
protein
0.0001 0.145 1.12 48
SCO2605 Hypothetical protein
SCC88.16
0.0002 0.140 1.36 36
SCO4187 Putative membrane
protein
0 0.040 1.52 36
SCO4709/rplP 50S ribosomal protein L16 0.0001 0.119 1.16 36
SCO6329 Hypothetical protein
SC10H5.05
0.0001 0.115 1.38 60
SCO6809 Putative integral
membrane transport
protein
0.0001 0.124 1.41 60
SCO7665 Hypothetical protein 0.0002 0.131 1.07 36
SCO7801 Putative membrane
protein
0.0002 0.131 1.39 60
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tional start point) plus 100 bp inside the ORF (
100) were used to
perform the experiments and are referred to henceforth as “pro-
moters*” (SCOXXXXp). Most of the identified targets that were
bound in vivo by the AbrC3 protein (Table 5) were also able to be
bound in vitro with a high specificity, including actII-ORF4p,
abrC3p, SCO0736p, absR1p, and SCO6809p (Fig. 3A to D and H).
The promoters* of SCO2113 and bdtA were bound with less spec-
ificity (Fig. 3E and F), and some promoters*, such as SCO4709p,
did not yield mobility shifts in vitro (Fig. 3G). Competition exper-
iments to verify the specificity of AbrC3 binding to each pro-
moter* were conducted by adding different amounts of the corre-
sponding unlabeled DNA or different amounts of sheared salmon
sperm DNA to the binding reaction mixtures.
Identification of a putative consensus AbrC3-binding site.
Aligning the 500-bp upstream sequences (including the first 100
bp of the respective ORFs) of genes enriched for AbrC3 in the
ChIP-chip and EMSA analyses by using the RSAT consensus
alignment tool (http://rsat.ulb.ac.be/) identified a minimal con-
TABLE 4 AbrC3 ChIP-chip targets selected by high enrichment ratiose
Regulated genea Enrichment ratiob Predicted function of regulated gene Time (h)c Predicted binding site sequenced
SCO0167 2.45 Conserved hypothetical protein SCJ1.16c 36 354-GAAGGGGGCG-363
SCO0951 2.22 Putative transport system permease protein 36 329-GGTCGCCTTC-318
SCO1391 5.44 Crr, phosphoenolpyruvate-protein phosphotransferase 48 1113- GAAGGCGGCG-1122
SCO3020 4.22 Putative integral membrane protein 48 Not found
SCO3263 2.60 Conserved hypothetical protein 36 240-GTTCGCCTTC-231
SCO3334 5.70 TrpS, tryptophanyl tRNA synthetase 48 387-GGCCGCGTTC-378
SCO3590 2.54 VanR, putative TCS response regulator 36 Not found
SCO3992 2.45 Hypothetical protein 36 Not found
SCO4075 6.32 RagA, ABC transport protein, ATP-binding subunit 48 Not found
SCO4123 5.02 Putative TCS response regulator 48 674-GAACGCGACC-665
SCO4596 2.24 AbrC3, TCS response regulator 60 137-CTTCCCGTTC-128
SCO4630 2.78 Hypothetical protein 36 Not found
SCO5085 2.23 ActII-ORF4, ACT cluster activator protein 36 72-GAAGGCGACC-81
SCO5236 2.86 NagB, putative glucosamine phosphate isomerase 48 213-GGTCGCGTTC-204
SCO5330 3.26 Hypothetical protein SC6G9.03c 36 975-GAAGGGGGCG-966
SCO5332 2.21 Hypothetical protein 36 1134-CTTCGCCTTC-1143
SCO5632 2.36 Hypothetical protein SC6A9.3 36 1261-GAACGGGACG-1252
SCO5638 2.76 Integral membrane protein 36 Not found
SCO5691 2.24 Putative secreted sugar hydrolase 48 777-GAACGCGGCG-768
SCO5729 2.33 Conserved hypothetical protein SC3C3.15c 36 Not found
SCO5912 4.30 Probable secreted protease 48 54-CTCCCCCTTC-45
SCO5966 2.24 Putative oxidase 48 803-GAAGGCGGAC-794
SCO6273 2.18 CpkC, putative type I polyketide synthase 48 3138-CGCCCCGTTC-3147
SCO6732 2.29 Putative fatty acid oxidative multifunctional enzyme 36 1140-GAAGGCGGCC-1149
SCO6820 2.94 Putative oxidoreductase 48 519-GAACGCGGCC-510
SCO6941 2.55 CvnC8, hypothetical protein SC1G8.13c 36 306-GGCCGCCTTC-297
SCO6951 2.55 Conserved hypothetical protein 36 411-CGCCGCGTTC-402
SCO6992 2.78 AbsR1, regulatory protein 48 321-GAAGGGGACG-312
SCO7077 2.24 Putative integral membrane protein 36 294-GAAGGCGGCG-285
SCO7545 2.45 Putative ABC transport protein, ATP-binding component 48 369-GGCCGCGTTC-360
a Putative AbrC3 target genes indicated by the ChIP-chip analysis.
b AbrC3-DNA interaction affinity.
c Time in the ChIP-chip assay at which the shown enrichment ratio was found.
d The consensus binding site sequence is 5=-GAASGSGRMS-3=. Numbers indicate the position of the sequence relative to the start codon of the corresponding gene.
e Genes that also had differential transcription profiles are shown in bold.
TABLE 5 AbrC3 overlapping targets in ChIP-chip and transcriptome analysesd
Gene Enrichment ratioa Predicted function of regulated gene Time (h)b Predicted binding site sequencec
SCO0736 1.50 Putative secreted protein 36 53-GAAGGCGACC-44
SCO2113 1.59 Bfr, putative bacterioferritin 48 26-GTTCCCGTTC-17
SCO3328 1.48 BdtA, hypothetical protein 48 46-GAAGGGGAAG-37
SCO4596 2.24 AbrC3, TCS response regulator 60 137-CTTCCCGTTC-128
SCO4709 1.89 RplP, 50S ribosomal protein L16 36 Not found
SCO5085 2.23 ActII-ORF4, ACT cluster activator protein 36 72-GAAGGCGACC-81
SCO6809 1.77 Putative integral membrane transport protein 48 112-GAAGGCGGAC-103
SCO6992 2.78 AbsR1, regulatory protein 48 321-GAAGGGGACG-312
a AbrC3-DNA interaction affinity by ChIP-chip analysis.
b Time in the ChIP-chip assay at which the shown enrichment ratio was found.
c The consensus binding site sequence is 5=-GAASGSGRMS-3=. Numbers indicate the position of the sequence related to the start codon of the corresponding gene.
d The genes shown in bold are upregulated. The other genes in the table are downregulated.
AbrC3 Regulon of Streptomyces coelicolor
April 2014 Volume 80 Number 8 aem.asm.org 2423
 o
n
 June 28, 2016 by guest
http://aem
.asm
.org/
D
ow
nloaded from
 
sensus binding site for AbrC3. A common 10-bp sequence (5=-G
AASGSGRMS-3=) was present in all of the putative promoters of
the identified target genes and was absent in the ones that did not
yield mobility shifts in vitro, such as SCO4709p (Fig. 4A). This
putative AbrC3-binding sequence was present within the ORF of
actII-ORF4, at positions
72 to
81 (from the translational start
codon), near one of the described target sequences of the regulator
protein AtrA (44) (Fig. 5). This sequence was also found in 23 of
30 of the genes identified by ChIP-chip analysis (Table 4).
The functionality of this putative AbrC3-binding sequence was
demonstrated by EMSAs using different fragments of actII-ORF4p
or deleting the putative binding sequence (Fig. 4B). Only the
whole promoter* region (fragment 1, also used for Fig. 3) or a 3=
part of the promoter* that included the 10-base sequence gener-
ated a mobility shift in the presence of the AbrC3 protein (Fig. 4B,
panels 1 and 4). Conversely, the mobility shift did not take place
when the 10-base sequence was removed (see Materials and Meth-
ods) (Fig. 4B, panel 5); controls used to demonstrate the specific-
ity of AbrC3 binding to the 3= segment of the promoter* (fragment
4) are shown in Fig. 4C. This result clearly indicated that the se-
quence (5=-GAAGGCGACC-3=) was essential in the direct regu-
lation of actII-ORF4 expression by the AbrC3 regulator.
The importance of this sequence in the binding of AbrC3
was also demonstrated by an EMSA with absR1p, another direct
target of this regulator. The elimination of the proposed bind-
ing sequence (5=-GAAGGGGACG-3=) originated the sequence
absR1pDel, which was unable to bind AbrC3, and therefore the
shifted band was not observed (see Fig. S2 in the supplemental
material).
Moreover, EMSAs were performed using shorter DNA probes
consisting of a 50-bp labeled oligonucleotide (resulting from an-
nealing two long, complementary oligonucleotides, SRG119 and
SRG120 [see Table S2 in the supplemental material]) correspond-
ing to a small fragment from actIIORF4p and containing the pre-
dicted binding sequence (probe 1), and also another artificially
labeled oligonucleotide of the same size, containing this sequence
but surrounded by foreign DNA (probe 2, resulting from anneal-
ing of oligonucleotides SRG121 and SRG122 [see Table S2]). The
FIG 3 EMSAs of different concentrations of AbrC3 protein with ChIP-chip-selected promoters. (A) actII-ORF4p; (B) abrC3p; (C) SCO0736p; (D) absR1p
(SCO6992p); (E) SCO2113p; (F) bdtAp (SCO3328p); (G) SCO4709p; (H) SCO6809p. S, specific competition control (adding the corresponding unlabeled specific
probe); N, nonspecific competitor DNA (100-fold molar excess of sheared sperm salmon DNA); BSA, specific protein control (4 M BSA).
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results (see Fig. S3) showed the ability of AbrC3 to bind specifi-
cally to probe 1 and also to the artificial probe 2. Therefore, these
10 nucleotides (5=-GAAGGCGACC-3=) were enough to recruit
the protein.
DISCUSSION
AbrC3 directly regulates actII-ORF4 expression. An integrated
global ChIP-chip and transcriptome analysis of an S. coelicolor
parent strain and an abrC3 mutant derivative has identified the
regulon of the response regulator AbrC3. actII-ORF4, the path-
way-specific regulator of ACT, is one of its direct targets, as cor-
roborated by EMSA in vitro. A 10-bp sequence, 5=-GAASGSGRM
S-3=, identified by RSAT consensus alignment of the putative
promoters* targeted by AbrC3, defines the AbrC3-binding site. In
the case of actII-ORF4, the binding sequence (5=-GAAGGCGAC
C-3=) is found within the ORF, at positions
72 to
81 (from the
translational ATG start codon) (Fig. 5). This is not the first time
that a transcriptional regulator-binding site has been found
within the actII-ORF4 coding sequence; there are two other regu-
lators, AtrA and Crp, whose binding sites are at positions
45 to

69 (44) and
24 to
38 (45), respectively. DNase footprinting
assays using selected AbrC3-associated sequences failed to yield a
DNase-protected region (data not shown); we consider that the
observed poor solubility of AbrC3 in vitro may account for the
incomplete shifting of template DNA obtained in the EMSAs and
for our failure to observe a footprint. Nevertheless, this consensus
sequence has been shown to be indispensable for AbrC3 binding
to actII-ORF4p (Fig. 4) and to another of its targets (absR1p) (see
Fig. S2 in the supplemental material). We speculate that binding
of AbrC3 to actII-ORF4p at 36 h may be necessary for the recruit-
ment of other regulators and that the binding of these regulators is
necessary for the first steps of actII-ORF4 expression: after this
initial recruitment, the regulators are subsequently released from
the promoter* to allow expression of downstream genes.
FIG 4 Identification of a putative AbrC3-binding sequence in different genes. (A) Consensus sequence identified by RSAT consensus alignment of putative
promoters* (upstream sequences up to400 bp plus
100 bp from the translational start point) of genes identified by ChIP-chip and EMSAs. (B) EMSAs of
different fragments of the actII-ORF4 promoter* region with 4 M AbrC3 (the top panel shows the amplified fragment locations in the promoter*). (C) EMSA
of different concentrations of the AbrC3 protein with the actII-ORF4 fragment 4 promoter*. S, specific competition control (adding 100-fold molar excess of
unlabeled specific probe); N, nonspecific competitor DNA (adding 100-fold excess of sheared sperm salmon DNA); BSA, specific control 2 (adding 4 M BSA
protein).
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The expression of the ACT-specific pathway regulator actII-
ORF4 is under the control of different regulatory proteins that
respond to diverse signaling routes in S. coelicolor, such as PhoPR
(46), RapA1A2 (47), the LAL regulators SCO0877 and SCO7173
(48), and the ECF SigT (49), among others (reviewed by van
Wezel and McDowall [3]). To date, demonstration of the direct
binding of transcription factors to the actII-ORF4 promoter re-
gion has been limited (Fig. 5). In vitro binding assays (EMSAs)
have shown that the AtrA protein binds to the actII-ORF4 pro-
moter (44). More recently, DNA affinity capture assays have
shown the capability of four more proteins (SCO0310, SCO3932,
SCO5405, and AdpA) to bind to the actII-ORF4 promoter (15).
Among the TCSs implicated in antibiotic production, thus far,
only AbsA2 has been shown to bind to the actII-ORF4 promoter in
vivo (50). Very recently, EMSAs demonstrated in vitro binding of
the TCSs DraRK and AfsQ1Q2 to the actII-ORF4 promoter (51,
52). Control of secondary metabolism by the global regulator Crp
was also recently described, and Crp binding to actII-ORF4 was
detected by ChIP-chip analysis, with both of the described binding
sites located within the ORF, at positions
24 to
38 and
234 to

248 (Fig. 5) (45).
AbrC3 regulon. The putative binding sequence (5=-GAASGS
GRMS-3=) defined in this work is present in 23 of the 30 genes with
the highest binding enrichment levels (wild-type AbIP/NoIP ver-
sus abrC3 AbIP/NoIP enrichment ratios obtained in the ChIP-
chip assay) (Table 4). The position of the putative binding se-
quence is typically upstream of the respective ORF, suggesting
regulation of the gene downstream of the binding site. However,
in some cases, the target sequences are within the coding se-
quences. This feature is coincident with data described previously
in the study of the regulation exerted by the protein Crp, where
more than 50% of all Crp-associated sequences were mapped
within ORFs (45). The regulatory role of these sequences located
inside the ORFs is not clear, and in a recent study using ChIP-
sequencing (ChIP-seq) and chromatin affinity precipitation se-
quencing (ChAP-seq) technologies to characterize the AdpA
regulon, it was found that approximately 75% of the in vivoAdpA-
binding sites apparently have no function in the regulation of gene
expression (53).
Conversely, it is also possible that some bona fide AbrC3 targets
were missed in this study, because the antibody does not recognize
its epitopes when AbrC3 is one of several transcription factors
bound to the promoter regions. It is known that false-negative
results can occur in ChIP-chip studies (38).
Pleiotropic regulation by the abrC TCS. The pleiotropic phe-
notype of the triple abrC1C2C3 mutant (13) is different (de-
creased CDA production) from the phenotype of the RR gene
deletion mutant, i.e., the abrC3 strain. This result suggests that
other RRs may be controlled by the kinases of this TCS, such as the
orphan RR SCO2281, proposed by Wang et al. to be recognized by
AbrC2 (54). It is known that the biosynthetic RED genes are ex-
pressed early, so the existence of direct AbrC3 regulation of the
promoter regions of redD or redZ cannot yet be excluded for the
experimental conditions tested. If the RED cluster regulation by
AbrC3 is indirect, this could be exerted through the regulatory
cascade triggered by AfsS, which is one of the indirect AbrC3 tar-
gets (17, 18), or by sIHF, which is downregulated in the abrC3
mutant and is able to bind to the redD and redZ promoters
(15, 16).
Several transcriptional regulators whose genes were down-
regulated in our study could be responsible for the morphological
phenotype observed in theabrC3mutant, including sIHF, which
also binds to the bldDpromoter, a key regulator of development in
S. coelicolor (16); the extracytoplasmic function sigma factor WblE
(20, 21); and BdtA, a putative transcription factor regulated by
BldD and involved in morphological differentiation (22, 23).
ChIP-chip assays demonstrated that AbrC3 is an autoregula-
tor. No differential regulation between the wild-type strain and
the AbrC3 mutant of the two kinase-encoding genes of the AbrC
TCS system was identified in our ChIP-chip or transcriptome
analysis.
A summary of the main interactions within the AbrC3 regulon
deduced from our global in vivo analyses (ChIP-chip and tran-
scriptome analyses) is illustrated in the model depicted in Fig. 6.
We observed a global positive effect on secondary metabolism,
mainly on the ACT cluster, and morphological differentiation
through the direct interaction of AbrC3 with the different genes
mentioned above. This activation could also be facilitated by neg-
ative control of primary metabolism by AbrC3, through ribo-
somal proteins such as RplP. Indeed, another gene involved in
FIG 5 Locations of regulatory protein-binding sites in the actII-ORF4 promoter* region. Locations are shown for the binding sequences in the actII-ORF4
promoter* described in the literature for the AtrA, DraR, and AfsQ1 proteins, as well as the position of the deduced target sequence for AbrC3 identified in this
work.
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primary metabolism, acdH, was downregulated in the abrC3
mutant; this gene encodes an acyl-CoA dehydrogenase involved in
biosynthesis of precursors of ACT and RED, which could explain
the positive regulation of this gene by AbrC3. In addition, Wang
et al. have just reported in vitro evidence that abrC3 is a target
of AfsQ1 and that it positively regulates its expression. This
suggests that the function of AfsQ1Q2 is mediated at least
partly via the AbrC1/C2/C3 system, further illustrating the
complexity of the regulatory network governing antibiotic pro-
duction (Fig. 6) (51, 52).
The emergence of new antibiotic-resistant isolates makes new
antibiotic discovery and the improvement of their production
major challenges for microbial biotechnology. Widening our
knowledge regarding TCS involvement in antibiotic synthesis reg-
ulation can contribute to the rational design of new hyperpro-
ducer host strains through genetic manipulation of those complex
systems. Moreover, strategies involving TCSs could be used to
unveil new antimicrobial molecules that are not normally pro-
duced under laboratory culture conditions.
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